Skip to Content

Access to medicines

About 200 000 deaths from malaria each year could be averted if African governments follow new World Health Organisation (WHO) guidelines, soon to be released, and switch from the far less effective medication quinine to artesunate, according to Medecins Sans Frontieres (MSF).
MSF campaigns to challenge the high cost of existing medicines and the absence of treatment for many of the diseases affecting our patients.   Today, one third of the world's population lacks access to essential medicines. In the poorest parts of Africa and Asia this figure rises to half of the population. Too often, MSF cannot treat patients because the medicines are too expensive or they are no longer produced. Sometimes, the only drugs we have are highly toxic or ineffective and nobody is looking for a better cure.   MSF is advocating for a combination of policies to lower drug prices on a sustainable basis. These strategies include encouraging generic competition, voluntary discounts on branded drugs, global...
30 April 2012
XDR-TB, extreme drug resistant TB, MSF, MCC, TMC 207, turberculosis
XDR-TB survivor and peer counselor, Xoliswa Hermanus, helps a family member fit a mask to prevent TB infection during a home visit and group counseling session. Her mother, Jonas Cikizwa, is a woman infected with extremely drug-resistant tuberculosis (XDR-TB), HIV and diabetes. Photo: Jose Cendon.
Squabble over TB drug medical council prohibits use of Bedaquiline on critically ill TB patients. A drug with the potential to save the lives of drug-resistant TB suffers has been withheld until all clinical trials are completed. Despite a request by non-government organisations for the drug to be made available for compassionate use, the Medicines Control Council has refused. ...Medicins Sans Frontieres' advocacy officer, Mara Kardas-Nelson, said: "We're not trying to use Bedaquiline across the board but we want to use it for patients who have no other option."   Read full article below.
01 April 2012
MSF, Etxtreme drug resistant tuberculosis, XDR TB, TMC207, South Africa
Tsilana, an MSF nurse, prepares an injected TB drug for Jonas Cikizwa, a woman infected with extremely drug-resistant tuberculosis (XDR-TB), HIV and diabetes. Photo: Jose Cendon.
A promising new drug now on trial offers the last hope for some patients with extreme drug resistant (XDR) tuberculosis. The life or death decision on whether to make it available rests with the Medicines Control Council (MCC). In a letter sent last week to the MCC and Health Minister Dr Aaron Motsoaledi, Medecins sans Frontieres (MSF) arid almost 50 doctors and scientists urged the regulatory body to consider the compassionate use of TMC207, a novel drug in Phase III trials... Read full article below.
14 March 2012
Patents, India, Generic drugs, Bayer, HIV/Aids, Pharmaceutical
a 38 year old semi-literate woman living in Mumbai. She has been living with HIV and multidrug resistant tuberculosis (MDR-TB) for the past 5 years. Photo: Bithin Das
INDIA'S move to strip German medicine maker Bayer of its exclusive rights to a cancer treatment has set a precedent that could extend to other treatments, including modern HIV/Aids medication, in a major blow to global pharmaceutical firms, experts say...Doctors Without Borders said the ruling meant that new medicines in India that are still under patent, including some of the latest HIV/Aids treatments, could potentially have generic versions produced for a fraction of the cost...Read full article below.
05 December 2011
Cryptococcal meningitis
The womens ward at the Homa Bay District Hospital in Western Kenya.
  Download the report Access to Essential Medicines: Ten Stories That Mattered in 2011   2011 marks the ten-year anniversary of two events that have helped shape people’s ability in developing countries to access quality, affordable medical care. First, the signing of the Doha Declaration, in which governments affirmed the need to prioritize health over trade: access to affordable medicines over intellectual property rights. But a decade later, the struggle to access medicines in developing countries continues. One key fault line is India, which is home of the most quality affordable medicines used in the developing world, but which faces...
21 December 2011
A list of "Ten Stories that Mattered in Access to Medicines in 2011"  was released today by the international medical humanitarian organisation Médecins Sans Frontières/Doctors Without Borders (MSF). The list looks at developments in 2011 that had an impact—whether positive or negative—on people’s ability to access needed drugs, diagnostics, and vaccines in developing countries. Download the report Access to Essential Medicines: Ten Stories That Mattered in 2011   For the diseases our medical teams encounter every day in places where we work, 2011 was a year of both critical progress and dangerous backsliding,” said Dr. Tido von Schoen-...
20 December 2011
Ten Stories That Mattered in 2011
Access to Essential Medicines: Ten Stories That Mattered in 2011
Through its Access Campaign, MSF has been closely following the developments in the world of access to medicines, vaccines, and diagnostics.
17 November 2011
medicines from MSF
Palestinian woman and children provided with medicines from MSF
Health facilities in the Gaza Strip face a serious shortage of drugs and medical supplies. In late September, 36% of essential drugs were lacking. While MSF makes regular donations, no aid actor can meet the full range of needs. Palestinian woman and children provided with medicines from MSF. Photo: Juan Carlos Tomasi The Israeli embargo of the Gaza Strip, which began in 2007, together with years of financial crisis within the Palestinian Authority in Ramallah and the chronic lack of cooperation between the Palestinian Authority and Gaza authorities, have caused harm and threaten Gaza's health system and its patients.   Last spring, drug companies stopped supplying the Palestinian Authority....
06 October 2011
Intervalo! teams from Mozambique, Malawi, Zimbabwe, Swaziland and South Africa
INTERVALO! teams
To raise awareness about HIV/AIDS and the challenges in treating the epidemic in southern Africa, MSF hosted the INTERVALO! sporting event in Maputo, Mozambique on 14 September, midway during the 10th All Africa Games. The event brought together 24 athletes, made up of patients living positively with HIV along with MSF staff involved in HIV care from 5 Southern African countries – Malawi, Mozambique, South Africa, Swaziland and Zimbabwe. INTERVALO! highlighted the determination and commitment of people on the frontlines of the fight against the HIV/AIDS epidemic, and demonstrated the positive impact of antiretroviral drugs in fighting a disease that wipes out 2 million people worldwide each year. Each of the fun sporting events...
Syndicate content